View in EDS

Bridging preclinical science to clinical design in the development of long-acting injectables: IQ Consortium Industry Perspectives.

Saved in:
Bibliographic Details
Title: Bridging preclinical science to clinical design in the development of long-acting injectables: IQ Consortium Industry Perspectives.
Authors: Bao Q; Synthetic Product Development, Alexion, AstraZeneca Rare Disease, New Haven, CT, USA. Electronic address: quanying.bao@alexion.com., Clarke JG; Manufacturing Science and Technology, Global Supply Chain, GSK, Ware, UK., Curran DW; Analytical Development, GSK, Collegeville, PA, USA., Duvnjak M; Technical Research & Development, Novartis Pharma AG, Basel, Switzerland., Goyal N; Clinical Pharmacology and Pharmacometrics, Johnson & Johnson, Titusville, NJ, USA., Heimbach T; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, NJ, USA., Jain KH; Analytical Development and Operations, Gilead Sciences, Foster City, CA, USA., Pawar P; Formulation and Process Development, Gilead Sciences, Foster City, CA, USA., Ragoonanan V; Drug Product Design and Development, AbbVie, Irvine, CA, USA., Saha P; Drug Product Development, GSK, Collegeville, PA, USA., Shaik NA; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., South San Francisco, CA, USA., Vargo R; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., West Point, PA, USA., Wan B; Drug Product Development & Biopharm, Sanofi, Cambridge, MA, USA.
Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 Jul 10; Vol. 395, pp. 114959. Date of Electronic Publication: 2026 Apr 27.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42055299
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bridging preclinical science to clinical design in the development of long-acting injectables: IQ Consortium Industry Perspectives.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bao+Q%22">Bao Q</searchLink>; Synthetic Product Development, Alexion, AstraZeneca Rare Disease, New Haven, CT, USA. Electronic address: quanying.bao@alexion.com.<br /><searchLink fieldCode="AU" term="%22Clarke+JG%22">Clarke JG</searchLink>; Manufacturing Science and Technology, Global Supply Chain, GSK, Ware, UK.<br /><searchLink fieldCode="AU" term="%22Curran+DW%22">Curran DW</searchLink>; Analytical Development, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Duvnjak+M%22">Duvnjak M</searchLink>; Technical Research & Development, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Goyal+N%22">Goyal N</searchLink>; Clinical Pharmacology and Pharmacometrics, Johnson & Johnson, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Heimbach+T%22">Heimbach T</searchLink>; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jain+KH%22">Jain KH</searchLink>; Analytical Development and Operations, Gilead Sciences, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pawar+P%22">Pawar P</searchLink>; Formulation and Process Development, Gilead Sciences, Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ragoonanan+V%22">Ragoonanan V</searchLink>; Drug Product Design and Development, AbbVie, Irvine, CA, USA.<br /><searchLink fieldCode="AU" term="%22Saha+P%22">Saha P</searchLink>; Drug Product Development, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shaik+NA%22">Shaik NA</searchLink>; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Vargo+R%22">Vargo R</searchLink>; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., West Point, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wan+B%22">Wan B</searchLink>; Drug Product Development & Biopharm, Sanofi, Cambridge, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2026 Jul 10; Vol. 395, pp. 114959. <i>Date of Electronic Publication: </i>2026 Apr 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42055299
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jconrel.2026.114959
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 114959
    Titles:
      – TitleFull: Bridging preclinical science to clinical design in the development of long-acting injectables: IQ Consortium Industry Perspectives.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bao Q
      – PersonEntity:
          Name:
            NameFull: Clarke JG
      – PersonEntity:
          Name:
            NameFull: Curran DW
      – PersonEntity:
          Name:
            NameFull: Duvnjak M
      – PersonEntity:
          Name:
            NameFull: Goyal N
      – PersonEntity:
          Name:
            NameFull: Heimbach T
      – PersonEntity:
          Name:
            NameFull: Jain KH
      – PersonEntity:
          Name:
            NameFull: Pawar P
      – PersonEntity:
          Name:
            NameFull: Ragoonanan V
      – PersonEntity:
          Name:
            NameFull: Saha P
      – PersonEntity:
          Name:
            NameFull: Shaik NA
      – PersonEntity:
          Name:
            NameFull: Vargo R
      – PersonEntity:
          Name:
            NameFull: Wan B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 07
              Text: 2026 Jul 10
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-4995
          Numbering:
            – Type: volume
              Value: 395
          Titles:
            – TitleFull: Journal of controlled release : official journal of the Controlled Release Society
              Type: main
ResultId 1